- Fecal Incontinence
This activity has been designed to meet the educational needs of gastroenterologists, physician assistants, and nurse practitioners involved in the management of IBD
Upon completion of this activity, participants should be better able to:
Distinguish among available treatment modalities for inflammatory bowel disease and select appropriate therapies based on patient characteristics
Differentiate among available 5-ASA formulations and describe their use separately or in combination in the management of ulcerative colitis
Discuss the most recent data on the risks and benefits of immunosuppressive therapies
Describe the most recent data on the selection and use of biologics in patients with inflammatory bowel disease
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and the Gi Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: February 22, 2012Expiration Date: February 22, 2013 EXPIRED
Physician Disclosure Statement
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. The Gi Health Foundation staff and Purdue University College of Pharmacy staff have no relationships to disclose.
This material is supported by educational grants from Abbott; Janssen Biotech, Inc.; Prometheus Labs; Salix Pharmaceuticals, Inc.; and UCB, Inc.